Pre-transplant blood transfusion and cyclosporin A induce long-term hamster cardiac xenograft survival in immunocompetent rats

Xenotransplantation

Volumn 12, Issue 1, 2005, Pages 63-71

  Vriens, Patrick W ^a,b   Stoot, Jan H ^a,b   Van Der Steenhoven, Tim J ^a,b   Hoyt, Grant ^a   Bouwman, Eelco ^b   Robbins, Robert C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood transfusion; Cyclosporin A; Heart; Xenotransplantation

Indexed keywords

ANTIBODY; CYCLOSPORIN A; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT SURVIVAL; HAMSTER; HEART TRANSPLANTATION; HYPERACUTE GRAFT REJECTION; IMMUNOCOMPETENCE; MALE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; BLOOD TRANSFUSION; CRICETINAE; CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; PREOPERATIVE CARE; RATS; RATS, INBRED LEW; RATS, NUDE; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 12144277315     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2004.00198.x     Document Type: Article

References (34)

1. GELLER RL, TURMAN MA, DALMASSO AP, PLATT JL. The natural immune barrier to xenotransplantation. J Am Soc Nephrol 1992; 3: 1189 [editorial].
2. PLATT JL, LINDMAN BJ, GELLER RL et al. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation 1991; 52: 1037.
3. PERPER RJ, NAJARIAN JS. Experimental renal heterotransplantation. I. In widely divergent species. Transplantation 1966; 4: 377.
4. PERPER RJ, NAJARIAN JS. Experimental renal heterotransplantion. II. Closely related species. Transplantation 1966; 4: 700.
5. LIN Y, VANDEPUTTE M, WAER M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 1997; 158: 5658.
6. LIM SML, WEE A, CHONG SM, WHITE DJG. An analysis of concordant xenograft rejection in the nude rat model. Transplant Proc 1990; 23: 2095.
7. TSUGITA M, RAO AS, SUN H et al. Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts. Transplant Proc 1996; 28: 696.
8. VRIENS PW, STOOT JH, HOYT G et al. Pre-transplant blood transfusion induces tolerance to hamster cardiac xenografts in athymic nude rats. Xenotransplantation 2001; 8: 247.
9. WHITE DJ. Cyclosporine A. Clinical pharmacology and therapeutic potential. Drugs 1982; 24: 322.
10. MARGREITER R. Impact of cyclosporine on organ transplantation. Transplant Proc 1991; 23: 2180.
11. KAHAN BD. Cyclosporine: A revolution in transplantation. Transplant Proc 1999; 31: 14S.
12. GREEN CJ. Experimental transplantation and cyclosporine. Transplantation 1988; 46: 3S.
13. VRIENS PW, NISCO SJ, HOYT EG et al. Tissue specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats. Transplantation 1994; 57: 1795.
14. KAHAN BD. Cyclosporine A: A selective anti-T cell agent. Clin Haematol 1982; 11: 743.
15. STEINBRUCHEL DA, NIELSEN B, KEMP E. Treatment of hamster heart to rat xenotransplantation. Transpl Immunol 1994; 2: 3.
16. MICHLER RE, MCMANUS RP, SMITH CR et al. Prolongation of primate cardiac xenograft survival with cyclosporine. Transplantation 1987; 44: 632.
17. HOMAN WP, WILLIAMS KA, FABRE JW, MILLARD PR, MORRIS PJ. Prolongation of cardiac xenograft survival in rats receiving cyclosporine A. Transplantation 1981; 31: 164.
18. KNECHTLE SJ, HALPERIN EC, BOLLINGER RR. Xenograft survival in two species combinations using total-lymphoid irradiation and cyclosporine. Transplantation 1987; 43: 173.
19. van den BOGAERDE J, ASPINALL R, WANG MW et al. Induction of long-term survival of hamster heart xenografts in rats. Transplantation 1991; 52: 15.
20. HASAN RI, van den BOGAERDE J, FORTY J et al. Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy. Transplant Proc 1992; 24: 517.
21. LIN Y, SOBIS H, VANDEPUTTE M, WAER M. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone. Transplant Proc 1994; 5: 3052.
22. ONO K, LINDSEY ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
23. TOTTERMAN TH, DANERSUND A, NILSSON K, KILLANDER A. Cyclosporin-A is selectively cytotoxic to human T cells in vitro. Blood 1982; 59: 1103.
24. LILLEHOJ HS, MALEK TR, SHEVACH EM. Differential effect of cyclosporine A on the expression of T and B lymphocyte activation antigens. J Immunol 1984; 133: 244.
25. FERNANDEZ C, PALACIOS R, MOLLER G. Cyclosporine A inhibits thymus-dependent but not thymus-independent immune responses induced by dextran B512. Scand J Immunol 1982; 16: 33.
26. ATTALLAH AM, URRITIA-SHAW A, YEATMAN TJ, FOLKS T. Effect of the new immunosuppressive agent, cyclosporin-A, on natural killer cell and antibody-dependent cell-mediated cytotoxic activity. Int Arch Allergy Appl Immunol 1981; 65: 465.
27. YANAGIHARA RH, ADLER WH. Cyclosporine A inhibits T cell mediated augmentation of mouse natural killer activity. Immunopharmacology 1982; 4: 243.
28. BROUARD S, VANHOVE B, GAGNE K et al. T cell repertoire alterations of vascularized xenografts. J Immunol 1999; 162: 3367.
29. LIN H, GASTMAN BR, WEI RQ et al. Phase-directed therapy and cardiac xenograft survival. J Surg Res 1997; 72: 84.
30. OPELZ G, TERASAKI PI. Prolongation effect of blood transfusions on kidney graft survival. Transplantation 1976; 22: 380.
31. KONERU B, HARRISON D, RIZWAN M et al. Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? Transplantation 1997; 63: 1587.
32. KATZ MR, BARNHART GR, GOLDMAN MH et al. Pre-transplant transfusions in cardiac allograft recipients. Transplantation 1987; 43: 499.
33. ALEXANDER JW, BABCOCK GF, FIRST MR et al. The induction of immunologic non-responsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial. Transplantation 1992; 53: 423.
34. KOVITHAVONGS T, SHARMA R, SCHLAUT J et al. Humoral and cell-mediated immune responses after donor-specific transfusion (DSBT). Transplant Proc 1989; 21: 1822.